Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-31 @ 7:34 PM
Study NCT ID:
NCT05256134
Status:
TERMINATED
Last Update Posted:
2025-06-12
First Post:
2022-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-13
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-25
First Submit QC Date:
None
Study First Post Date:
2022-02-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-08
Results First Submit QC Date:
None
Results First Post Date:
2024-07-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-30
Last Update Post Date:
2025-06-12
Last Update Post Date Type:
ACTUAL